Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study

Y. Forslin; S. Shams; F. Hashim; P. Aspelin; G. Bergendal; J. Martola; S. Fredrikson; M. Kristoffersen-Wiberg; T. Granberg

doi:10.3174/ajnr.A5211

Research ArticleADULT BRAIN

Open Access

Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study

Y. Forslin, S. Shams, F. Hashim, P. Aspelin, G. Bergendal, J. Martola, S. Fredrikson, M. Kristoffersen-Wiberg and T. Granberg

American Journal of Neuroradiology July 2017, 38 (7) 1311-1316; DOI: https://doi.org/10.3174/ajnr.A5211

Y. Forslin

aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Y. Forslin

S. Shams

aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for S. Shams

F. Hashim

aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for F. Hashim

P. Aspelin

aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for P. Aspelin

G. Bergendal

aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

cNeurology (G.B., S.F.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for G. Bergendal

J. Martola

aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for J. Martola

S. Fredrikson

cNeurology (G.B., S.F.)

dClinical Neuroscience (S.F.), Karolinska Institutet, Stockholm, Sweden.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for S. Fredrikson

M. Kristoffersen-Wiberg

aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for M. Kristoffersen-Wiberg

T. Granberg

aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for T. Granberg

Article
Figures & Data
Supplemental
Info & Metrics
Responses
References
PDF

Data supplements

Files in this Data Supplement:

Supplemental Online Table

PreviousNext

In this issue

American Journal of Neuroradiology

Vol. 38, Issue 7

1 Jul 2017

Table of Contents
Index by author
Complete Issue (PDF)

Download PDF

Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study

Message Subject (Your Name) has sent you a message from American Journal of Neuroradiology

Message Body (Your Name) thought you would like to see the American Journal of Neuroradiology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cite this article

Y. Forslin, S. Shams, F. Hashim, P. Aspelin, G. Bergendal, J. Martola, S. Fredrikson, M. Kristoffersen-Wiberg, T. Granberg

Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study

American Journal of Neuroradiology Jul 2017, 38 (7) 1311-1316; DOI: 10.3174/ajnr.A5211

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

0 Responses

Respond to this article

Bookmark this article

User Name *

Password *

Remember my user name & password.

Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study

Y. Forslin, S. Shams, F. Hashim, P. Aspelin, G. Bergendal, J. Martola, S. Fredrikson, M. Kristoffersen-Wiberg, T. Granberg

American Journal of Neuroradiology Jul 2017, 38 (7) 1311-1316; DOI: 10.3174/ajnr.A5211

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Purchase

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
Responses
References
PDF

PubMed
Google Scholar

Cited By...

MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis
Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MS
Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologists Perspective
Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS
Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent
Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis

Crossref (48)
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates

Robert J. McDonald, Deborah Levine, Jeffrey Weinreb, Emanuel Kanal, Matthew S. Davenport, James H. Ellis, Paula M. Jacobs, Robert E. Lenkinski, Kenneth R. Maravilla, Martin R. Prince, Howard A. Rowley, Michael F. Tweedle, Herbert Y. Kressel

Radiology 2018 289 2
Gadolinium-based Contrast Media, Cerebrospinal Fluid and the Glymphatic System: Possible Mechanisms for the Deposition of Gadolinium in the Brain

Toshiaki Taoka, Shinji Naganawa

Magnetic Resonance in Medical Sciences 2018 17 2
Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency

Ilona A. Dekkers, Rick Roos, Aart J. van der Molen

European Radiology 2018 28 4
Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent

Danielle V. Bower, Johannes K. Richter, Hendrik von Tengg-Kobligk, Johannes T. Heverhagen, Val M. Runge

Investigative Radiology 2019 54 8
Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration

Julie Davies, Petra Siebenhandl-Wolff, Francois Tranquart, Paul Jones, Paul Evans

Archives of Toxicology 2022 96 2
Gadolinium-based contrast agents — review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients

Einat Blumfield, David W. Swenson, Ramesh S. Iyer, A. Luana Stanescu

Pediatric Radiology 2019 49 4
Gadolinium-based contrast agents in children

Michael N. Rozenfeld, Daniel J. Podberesky

Pediatric Radiology 2018 48 9
A Review of the Current Evidence on Gadolinium Deposition in the Brain

Richard Pullicino, Mark Radon, Shubhabrata Biswas, Maneesh Bhojak, Kumar Das

Clinical Neuroradiology 2018 28 2
Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies

Carlo A. Mallio, Àlex Rovira, Paul M. Parizel, Carlo C. Quattrocchi

Neuroradiology 2020 62 8
Current and Future MR Contrast Agents

Eric Lancelot, Jean-Sébastien Raynaud, Pierre Desché

Investigative Radiology 2020 55 9

ADULT BRAIN

Diagnostic Neuroradiology of Monoclonal Antibodies
Cerebral ADC Changes in Fabry Disease
ML for Glioma Molecular Subtype Prediction

Show more ADULT BRAIN

PATIENT SAFETY

Safety of Intrathecal Gadobutrol in Various Doses
Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol
Contrast-Induced Acute Kidney Injury in Radiologic Management of Acute Ischemic Stroke in the Emergency Setting

Show more PATIENT SAFETY

Main menu

User menu

Search

American Journal of Neuroradiology

Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study

Data supplements

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

ADULT BRAIN

PATIENT SAFETY

Similar Articles

Indexed Content

Cases

Special Collections

More from AJNR

Multimedia

Resources

About Us

American Society of Neuroradiology